The University of Chicago Header Logo


Mark J. Ratain to Topoisomerase II Inhibitors

This is a "connection" page, showing publications Mark J. Ratain has written about Topoisomerase II Inhibitors.
Connection Strength

  1. R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9. Eur J Cancer. 2009 Jul; 45(11):1904-8.
    View in: PubMed
    Score: 0.352
  2. Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer. J Clin Oncol. 2001 Apr 01; 19(7):2084-90.
    View in: PubMed
    Score: 0.200
  3. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes. Ann Oncol. 1992 Feb; 3(2):107-11.
    View in: PubMed
    Score: 0.106
  4. Etoposide pathway. Pharmacogenet Genomics. 2009 Jul; 19(7):552-3.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.